74417-44-0 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1-BROMOMETHYL-ISOQUINOLINE is used as a building block in organic synthesis for the preparation of various pharmaceuticals and agrochemicals, leveraging its bromine atom and methyl group to introduce these functional groups into more complex molecules, thereby enhancing the therapeutic and pesticidal properties of the final products.
Used in Heterocyclic Compound Synthesis:
1-BROMOMETHYL-ISOQUINOLINE is utilized as a reagent in the synthesis of heterocyclic compounds, contributing to the development of novel chemical entities with potential applications in various fields, including medicine, materials science, and chemical research.
Used in Specialty Chemical Production:
As a precursor, 1-BROMOMETHYL-ISOQUINOLINE plays a crucial role in the production of specialty chemicals, where its unique structure and functional groups are essential for creating high-value chemical products with specific properties and applications.
Used in Biological Research:
1-BROMOMETHYL-ISOQUINOLINE is studied for its potential biological activities, such as anti-inflammatory and antimicrobial properties, indicating its possible use in the development of new therapeutic agents and treatments for various diseases and infections.
Check Digit Verification of cas no
The CAS Registry Mumber 74417-44-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,4,1 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 74417-44:
(7*7)+(6*4)+(5*4)+(4*1)+(3*7)+(2*4)+(1*4)=130
130 % 10 = 0
So 74417-44-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H8BrN/c11-7-10-9-4-2-1-3-8(9)5-6-12-10/h1-6H,7H2
74417-44-0Relevant articles and documents
CASPASE INHIBITORS BASED ON PYRIDAZINONE SCAFFOLD
-
Page/Page column 57-58, (2008/06/13)
The present invention relates to a pyridazinone derivative which can be used as a caspase inhibitor, process for the preparation thereof, and pharmaceutical composition for inhibiting caspase comprising the same.